Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $20.20 and traded as high as $20.42. Sabra Healthcare REIT shares last traded at $20.15, with a volume of 2,011,622 shares.

Analyst Ratings Changes

Several research firms have recently commented on SBRA. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, August 4th. UBS Group set a $25.00 price objective on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Finally, Truist Financial upped their target price on Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Seven investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.23.

Sabra Healthcare REIT Price Performance

The firm has a market capitalization of $5.04 billion, a P/E ratio of 75.93, a price-to-earnings-growth ratio of 1.53 and a beta of 0.65. The business has a fifty day moving average of $20.73 and a 200-day moving average of $20.20. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business had revenue of $230.11 million for the quarter, compared to the consensus estimate of $219.39 million. During the same period in the previous year, the firm earned $0.38 EPS. The firm’s revenue was up 24.7% on a year-over-year basis. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were issued a $0.30 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 461.54%.

Insider Activity at Sabra Healthcare REIT

In related news, CEO Richard Matros sold 200,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the sale, the chief executive officer owned 1,657,686 shares of the company’s stock, valued at $34,529,599.38. The trade was a 10.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rothschild Investment LLC raised its stake in shares of Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares in the last quarter. Versant Capital Management Inc boosted its stake in Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 603 shares in the last quarter. Murphy & Mullick Capital Management Corp grew its holdings in Sabra Healthcare REIT by 100.8% during the fourth quarter. Murphy & Mullick Capital Management Corp now owns 2,008 shares of the real estate investment trust’s stock worth $38,000 after acquiring an additional 1,008 shares during the period. Integrated Wealth Concepts LLC acquired a new position in Sabra Healthcare REIT during the second quarter worth about $61,000. Finally, EverSource Wealth Advisors LLC raised its position in Sabra Healthcare REIT by 48.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 3,891 shares of the real estate investment trust’s stock worth $74,000 after acquiring an additional 1,267 shares in the last quarter. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties. The company primarily focuses on skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare operators under long-term agreements, including triple-net leases, and may provide mortgage loans or other forms of financing to healthcare providers. Its portfolio serves healthcare markets across the United States and Canada.

Founded in 2010 and headquartered in Irvine, California, Sabra became a publicly traded company in 2010.